# Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors

> **NCT05874063** · PHASE3 · RECRUITING · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 387 (estimated)

## Conditions studied

- Germ Cell Tumor

## Interventions

- **DRUG:** Thromboprophylaxis

## Key facts

- **NCT ID:** NCT05874063
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-17
- **Primary completion:** 2028-02
- **Final completion:** 2028-02
- **Target enrollment:** 387 (ESTIMATED)
- **Last updated:** 2025-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05874063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05874063, "Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05874063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*